SEB Asset Management AB »

Travere Therapeutics shares owned by SEB Asset Management AB

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by SEB Asset Management AB from 13F filings

Historical chart of SEB Asset Management AB investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by SEB Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by SEB Asset Management AB

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.4M 165k 56.81

More positions owned by SEB Asset Management AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Astrazeneca Ord (AZN)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Applied Materials (AMAT)

View all positions for SEB Asset Management AB

Top funds holding Travere Therapeutics

Henderson Group
Jupiter Topco
BlackRock
FMR
State Street Corporation
Bank of America Corporation
Vanguard Capital Management
Perceptive Advisors
Nomura Asset Management International
Adage Capital Partners GP
Geode Capital Management
Rock Springs Capital Management
Armistice Capital
Kynam Capital Management
Stephens Investment Management Group

View all funds holding Travere Therapeutics